F Brañas

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

Polymyalgia rheumatica and giant-cell arteritis

EPIDEMIOLOGY OF THE VASCULITIDES

Ischemic optic neuropathy

Trial of Tocilizumab in Giant-Cell Arteritis

The Erythrocyte Sedimentation Rate Is Associated with the Development of Visual Complications in Biopsy-Proven Giant Cell Arteritis

Immune mechanisms in medium and large-vessel vasculitis

BSR and BHPR guidelines for the management of giant cell arteritis

Stroke associated with giant cell arteritis: a population-based study

Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis

A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant‐cell arteritis

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

Giant Cell Arteritis versus Takayasu Arteritis: An Update

Polymyalgia Rheumatica and Giant Cell Arteritis

Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis.

Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients